Synthesis and antibacterial activity of novel (un)substituted benzotriazolyl oxazolidinone derivatives. 2005

Prasad P Dixit, and Prathap S Nair, and Vijaykumar J Patil, and Sanjay Jain, and Sudershan K Arora, and Neelima Sinha
Medicinal Chemistry Division, New Chemical Entity Research, Lupin Research Park, 46/47A, Village Nande, Taluka Mulshi, Pune 411 042, Maharashtra, India.

A series of novel (un)substituted benzotriazolyl oxazolidinone derivatives has been synthesized and tested for in vitro antibacterial activities by MIC determination against a panel of susceptible and resistant Gram-positive and Gram-negative microorganisms, some of which are resistant to methicillin and vancomycin. Compounds 20, 21, 24, 29 and 30 from this series were found to be equipotent or more potent than linezolid in vitro.

UI MeSH Term Description Entries
D008712 Methicillin One of the PENICILLINS which is resistant to PENICILLINASE but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection. Penicillin, Dimethoxyphenyl,Methicillin Hydrate, Monosodium Salt,Methicillin Monohydrate, Monosodium Salt,Methicillin Sodium,Meticillin,Metin,Staphcillin,Dimethoxyphenyl Penicillin
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000069349 Linezolid An oxazolidinone and acetamide derived ANTI-BACTERIAL AGENT and PROTEIN SYNTHESIS INHIBITOR that is used in the treatment of GRAM-POSITIVE BACTERIAL INFECTIONS of the skin and respiratory tract. Linezolide,N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide,PNU-100766,U 100766,U-100766,Zyvox,100766, U,PNU 100766,PNU100766,U100766
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014640 Vancomycin Antibacterial obtained from Streptomyces orientalis. It is a glycopeptide related to RISTOCETIN that inhibits bacterial cell wall assembly and is toxic to kidneys and the inner ear. AB-Vancomycin,Diatracin,VANCO-cell,Vanco Azupharma,Vanco-saar,Vancocin,Vancocin HCl,Vancocine,Vancomicina Abbott,Vancomicina Chiesi,Vancomicina Combino Phar,Vancomicina Norman,Vancomycin Hexal,Vancomycin Hydrochloride,Vancomycin Lilly,Vancomycin Phosphate (1:2),Vancomycin Phosphate (1:2), Decahydrate,Vancomycin Sulfate,Vancomycin-ratiopharm,Vancomycine Dakota,Hydrochloride, Vancomycin,Sulfate, Vancomycin

Related Publications

Prasad P Dixit, and Prathap S Nair, and Vijaykumar J Patil, and Sanjay Jain, and Sudershan K Arora, and Neelima Sinha
September 2004, Bioorganic & medicinal chemistry letters,
Prasad P Dixit, and Prathap S Nair, and Vijaykumar J Patil, and Sanjay Jain, and Sudershan K Arora, and Neelima Sinha
February 2022, Molecules (Basel, Switzerland),
Prasad P Dixit, and Prathap S Nair, and Vijaykumar J Patil, and Sanjay Jain, and Sudershan K Arora, and Neelima Sinha
December 2019, Bioorganic & medicinal chemistry letters,
Prasad P Dixit, and Prathap S Nair, and Vijaykumar J Patil, and Sanjay Jain, and Sudershan K Arora, and Neelima Sinha
April 2000, Bioorganic & medicinal chemistry letters,
Prasad P Dixit, and Prathap S Nair, and Vijaykumar J Patil, and Sanjay Jain, and Sudershan K Arora, and Neelima Sinha
January 2015, Bioorganic & medicinal chemistry letters,
Prasad P Dixit, and Prathap S Nair, and Vijaykumar J Patil, and Sanjay Jain, and Sudershan K Arora, and Neelima Sinha
September 1999, Bioorganic & medicinal chemistry letters,
Prasad P Dixit, and Prathap S Nair, and Vijaykumar J Patil, and Sanjay Jain, and Sudershan K Arora, and Neelima Sinha
January 2009, Bioorganic & medicinal chemistry letters,
Prasad P Dixit, and Prathap S Nair, and Vijaykumar J Patil, and Sanjay Jain, and Sudershan K Arora, and Neelima Sinha
October 2006, Bioorganic & medicinal chemistry letters,
Prasad P Dixit, and Prathap S Nair, and Vijaykumar J Patil, and Sanjay Jain, and Sudershan K Arora, and Neelima Sinha
August 2012, Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences,
Prasad P Dixit, and Prathap S Nair, and Vijaykumar J Patil, and Sanjay Jain, and Sudershan K Arora, and Neelima Sinha
September 2010, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!